A genome-wide study of lipid response to fenofibrate in Caucasians-Reference-Cited by-同舟云学术

A genome-wide study of lipid response to fenofibrate in Caucasians

Published:2016-07 Issue:7 Volume:26 Page:324-333
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Irvin Marguerite R.,Rotroff Daniel M.,Aslibekyan Stella,Zhi Degui,Hidalgo Bertha,Motsinger-Reif Alison,Marvel Skylar,Srinivasasainagendra Vinodh,Claas Steven A.,Buse John B.,Straka Robert J.,Ordovas Jose M.,Borecki Ingrid B.,Guo Xiuqing,Chen Ida Y.D.,Rotter Jerome I.,Wagner Michael J.,Arnett Donna K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference45 articles.

1. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey;Ford;JAMA,2002

2. Plasma triglyceride as a risk factor for cardiovascular disease;Austin;Can J Cardiol,1998

3. Hypertriglyceridemia;Pejic;J Am Board Fam Med,2006

4. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease;Jorgensen;N Engl J Med,2014

5. Loss-of-function mutations in APOC3, triglycerides, and coronary disease;Crosby;N Engl J Med,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk;Genes;2023-11-09

3. Questionnaire-based exposome-wide association studies (ExWAS) reveal expected and novel risk factors associated with cardiovascular outcomes in the Personalized Environment and Genes Study;Environmental Research;2022-09

4. Identifying the Potential Roles of PBX4 in Human Cancers Based on Integrative Analysis;Biomolecules;2022-06-13

5. Fibrate pharmacogenomics: expanding past the genome;Pharmacogenomics;2020-03